ConductScience.org, home

Paper42908005PubMed

Sphingolipid metabolic subtyping defines SPHK1 as an oncogene and characterizes immunosuppressive TME features in gastric cancer.

Wang Z and 2 others. Cancer Cell Int, 2026.

Cite this record

ConductScience Library. Sphingolipid metabolic subtyping defines SPHK1 as an oncogene and characterizes immunosuppressive TME features in gastric cancer. Papers, record 42908005. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/42908005

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Sphingolipid metabolic subtyping defines SPHK1 as an oncogene and characterizes immunosuppressive TME features in gastric cancer.
Journal
Cancer Cell Int
Year
2026
Publication types
Journal Article
Revised in PubMed
2026-10-24

Source PubMed

Authors3

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Wang ZZeyu
2Yue ZZhuying
3Jiang CChengkai

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

Grants2

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
JZXKCTS-2024-06Jiading District Central Hospital Scientific Research Innovation Exploration ProgramPubMed
JDKW-2025-0028Jiading District Natural Science Research ProjectPubMed

Source PubMed

Download CSV of grants

References79

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
126662312SphK1 promotes tumor cell migration and invasion in colorectal cancer.Tumour Biol2016https://conductscience.org/library/papers/26662312PubMed
232402091Role of sphingolipid metabolism in neurodegeneration.J Neurochem2021https://conductscience.org/library/papers/32402091PubMed
337507302Sphingolipid metabolism and complement signaling in cancer progression.Trends Cancer2023https://conductscience.org/library/papers/37507302PubMed
440394027Sphingolipid metabolism-related genes as diagnostic markers in pneumonia-induced sepsis: the AUG model.Sci Rep2025https://conductscience.org/library/papers/40394027PubMed
539671294Metabolic reprogramming, sensing, and cancer therapy.Cell Rep2024https://conductscience.org/library/papers/39671294PubMed
629654831Fingolimod interrupts the cross talk between estrogen metabolism and sphingolipid metabolism within prostate cancer cells.Toxicol Lett2018https://conductscience.org/library/papers/29654831PubMed
725382749Sphingolipid metabolism and interorganellar transport: localization of sphingolipid enzymes and lipid transfer proteins.Traffic2015https://conductscience.org/library/papers/25382749PubMed
838077400Single-cell sequencing analysis related to sphingolipid metabolism guides immunotherapy and prognosis of skin cutaneous melanoma.Front Immunol2023https://conductscience.org/library/papers/38077400PubMed
937598157The global prevalence of gastric cancer in Helicobacter pylori-infected individuals: a systematic review and meta-analysis.BMC Infect Dis2023https://conductscience.org/library/papers/37598157PubMed
1040537868Sphingolipid metabolism-related genes for the diagnosis of metabolic syndrome by integrated bioinformatics analysis and Mendelian randomization identification.Diabetol Metab Syndr2025https://conductscience.org/library/papers/40537868PubMed
1135745168The Role of Obesity, Inflammation and Sphingolipids in the Development of an Abdominal Aortic Aneurysm.Nutrients2022https://conductscience.org/library/papers/35745168PubMed
1235846357Development of a Novel Sphingolipid Signaling Pathway-Related Risk Assessment Model to Predict Prognosis in Kidney Renal Clear Cell Carcinoma.Front Cell Dev Biol2022https://conductscience.org/library/papers/35846357PubMed
1334268882SphK1-driven autophagy potentiates focal adhesion paxillin-mediated metastasis in colorectal cancer.Cancer Med2021https://conductscience.org/library/papers/34268882PubMed
1428405684SphK1 modulates cell migration and EMT-related marker expression by regulating the expression of p-FAK in colorectal cancer cells.Int J Mol Med2017https://conductscience.org/library/papers/28405684PubMed
1520334489Targeting sphingolipid metabolism in head and neck cancer: rational therapeutic potentials.Expert Opin Ther Targets2010https://conductscience.org/library/papers/20334489PubMed
1640434736Potential of SPHK1 as a prognostic marker and therapeutic target in colorectal cancer: insights from bioinformatics and experimental analysis.Int J Surg2025https://conductscience.org/library/papers/40434736PubMed
1727811358Sphk1 promotes breast epithelial cell proliferation via NF-κB-p65-mediated cyclin D1 expression.Oncotarget2016https://conductscience.org/library/papers/27811358PubMed
1839578076SPHK1/S1PR1/PPAR-α axis restores TJs between uroepithelium providing new ideas for IC/BPS treatment.Life Sci Alliance2025https://conductscience.org/library/papers/39578076PubMed
1940665874Targeting SPHK1 in macrophages remodels the tumor microenvironment and enhances anti-PD-1 immunotherapy efficacy in colorectal cancer liver metastasis.Cancer Commun (Lond)2025https://conductscience.org/library/papers/40665874PubMed
2033506044Increased SPHK1 and HAS2 Expressions Correlate to Poor Prognosis in Pancreatic Cancer.Biomed Res Int2021https://conductscience.org/library/papers/33506044PubMed

See all 79 referencesDownload CSV of references

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Cited by
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/42908005

GET https://conductscience.org/api/papers/v1/42908005/references?page=2